Evidence map›Paper›PMID 29175850›Full record

ArticleMolecular systems biology2017

From word models to executable models of signaling networks using automated assembly.

Benjamin M Gyori, John A Bachman, Kartik Subramanian, Jeremy L Muhlich, Lucian Galescu, Peter K Sorger

Abstract read
In one paragraph

Article in Molecular systems biology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 88 papers.

0numbers the graph read from it
0cells of the map it votes in
88citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

88 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Unveiling toxicological adverse outcomes: toward construction and simulation of large-scale networks.Toxicological sciences : an official journal of the Society of Toxicology · 2026
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article

28 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Benjamin M GyoriLaboratory of Systems Pharmacology, Harvard Medical School, Boston, MA, USA.ORCID 0000-0001-9439-5346
John A BachmanLaboratory of Systems Pharmacology, Harvard Medical School, Boston, MA, USA.ORCID 0000-0001-6095-2466
Kartik SubramanianLaboratory of Systems Pharmacology, Harvard Medical School, Boston, MA, USA.
Jeremy L MuhlichLaboratory of Systems Pharmacology, Harvard Medical School, Boston, MA, USA.
Lucian GalescuInstitute for Human and Machine Cognition, Pensacola, FL, USA.
Peter K SorgerLaboratory of Systems Pharmacology, Harvard Medical School, Boston, MA, USA peter_sorger@hms.harvard.edu.ORCID 0000-0002-3364-1838

Funding

TRANSLATIONAL PHARMACOLOGY COREP50GM107618 · NIGMS · HARVARD MEDICAL SCHOOL · PI GOLAN, DAVID E. · 2014 to 2018
$10.8M
NIGMS NIH HHS P50 GM107618
6 · The paper itself

Abstract

Word models (natural language descriptions of molecular mechanisms) are a common currency in spoken and written communication in biomedicine but are of limited use in predicting the behavior of complex biological networks. We present an approach to building computational models directly from natural language using automated assembly. Molecular mechanisms described in simple English are read by natural language processing algorithms, converted into an intermediate representation, and assembled into executable or network models. We have implemented this approach in the Integrated Network and Dynamical Reasoning Assembler (INDRA), which draws on existing natural language processing systems as well as pathway information in Pathway Commons and other online resources. We demonstrate the use of INDRA and natural language to model three biological processes of increasing scope: (i) p53 dynamics in response to DNA damage, (ii) adaptive drug resistance in BRAF-V600E-mutant melanomas, and (iii) the RAS signaling pathway. The use of natural language makes the task of developing a model more efficient and it increases model transparency, thereby promoting collaboration with the broader biology community.

Indexed as

Gene Expression Regulation, NeoplasticModels, GeneticNatural Language ProcessingNeural Networks, ComputerAntineoplastic AgentsCell Line, TumorComputer SimulationDNA DamageDrug Resistance, NeoplasmEnzyme InhibitorsHumansIndolesLanguageMelanomaProto-Oncogene Proteins B-rafProto-Oncogene Proteins p21(ras)Antineoplastic AgentsBRAF protein, humanEnzyme InhibitorsIndolesProto-Oncogene Proteins B-rafProto-Oncogene Proteins p21(ras)SulfonamidesTumor Suppressor Protein p53Vemurafenibcomputational modelingnatural language processingsignaling pathways

Identifiers

PMID29175850
PMCPMC5731347

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.